Literature DB >> 8759074

Negative chronotropic effect of beta-blockade therapy reduces myocardial oxygen expenditure for nonmechanical work.

H Yamakawa1, M Takeuchi, H Takaoka, K Hata, M Mori, M Yokoyama.   

Abstract

BACKGROUND: The negative chronotropic effect of beta-blocking agents is likely to provide hemodynamic and energetic advantages. However, the negative chronotropic effect on cardiac energetics observed on the initiation of beta-blockade therapy has not been fully elucidated. METHODS AND
RESULTS: In 18 patients with heart failure, left ventricular pressure and volume, external work (EW), myocardial oxygen consumption per beat (total Vo2), mechanical efficiency (EW/total Vo2), and Vo2 for nonmechanical work (total Vo2-2.EW) were measured with the use of conductance catheter and Webster catheter at the following three states: under control conditions and after beta-blockade (0.15 +/- 0.07 mg/kg propranolol IV) with and without atrial pacing to keep the heart rate at control levels. Heart rate decreased after atrial pacing was stopped. EW decreased during beta-blockade with pacing and returned to the control level after pacing was stopped. Total Vo2 did not change during beta-blockade with or without pacing, whereas Vo2 for nonmechanical work increased with pacing and returned to the control level after pacing was stopped. As a result, mechanical efficiency decreased during beta-blockade with pacing and returned to the control level after pacing was stopped.
CONCLUSIONS: The negative chronotropic effect of a beta-blocking agent may offset the mechanoenergetical deterioration resulting from its negative inotropic effect through a reduction in oxygen expenditure for nonmechanical work. These findings suggest that the negative chronotropic effect is an important aspect of beta-blockade therapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8759074     DOI: 10.1161/01.cir.94.3.340

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

Review 1.  Potential interests of heart rate lowering drugs.

Authors:  T Laperche; D Logeart; A Cohen-Solal; R Gourgon
Journal:  Heart       Date:  1999-04       Impact factor: 5.994

Review 2.  Role of heart rate as a marker and mediator of poor outcome for patients with heart failure.

Authors:  John R Kapoor; Paul A Heidenreich
Journal:  Curr Heart Fail Rep       Date:  2012-06

3.  The Role of Ivabradine and Trimetazidine in the New ESC HF Guidelines.

Authors:  Ivan Milinković; Giuseppe Rosano; Yuri Lopatin; Petar M Seferović
Journal:  Card Fail Rev       Date:  2016-11

4.  Disopyramide improves the balance between myocardial oxygen supply and demand in patients with hypertrophic obstructive cardiomyopathy.

Authors:  K Niki; M Sugawara; R Asano; T Oka; Y Kondoh; S Tanino; K Iwade; N Magosaki; H Kasanuki; S Hosoda
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

5.  Beta blockers in heart failure: a comparison of a vasodilating beta blocker with metoprolol.

Authors:  J E Sanderson; S K Chan; C M Yu; L Y Yeung; W M Chan; K Raymond; K W Chan; K S Woo
Journal:  Heart       Date:  1998-01       Impact factor: 5.994

6.  Heart rate reduction by If-inhibition improves vascular stiffness and left ventricular systolic and diastolic function in a mouse model of heart failure with preserved ejection fraction.

Authors:  Jan-Christian Reil; Mathias Hohl; Gert-Hinrich Reil; Henk L Granzier; Mario T Kratz; Andrey Kazakov; Peter Fries; Andreas Müller; Matthias Lenski; Florian Custodis; Stefan Gräber; Gerd Fröhlig; Paul Steendijk; Hans-Ruprecht Neuberger; Michael Böhm
Journal:  Eur Heart J       Date:  2012-07-24       Impact factor: 29.983

7.  Renal denervation mitigates cardiac remodeling and renal damage in Dahl rats: a comparison with β-receptor blockade.

Authors:  Heitaro Watanabe; Yoshitaka Iwanaga; Yuki Miyaji; Hiromi Yamamoto; Shunichi Miyazaki
Journal:  Hypertens Res       Date:  2015-12-03       Impact factor: 3.872

8.  Is heart rate reduction more important than target dose in chronic heart failure therapy with a beta-blocker?

Authors:  Yong-Fang Guo; Yi An
Journal:  J Geriatr Cardiol       Date:  2011-12       Impact factor: 3.327

9.  Peripheral pulmonary artery stenosis in three cats.

Authors:  Takuma Aoki; Hiroshi Sunahara; Keisuke Sugimoto; Tetsuro Ito; Eiichi Kanai; Yoko Fujii
Journal:  J Vet Med Sci       Date:  2014-12-19       Impact factor: 1.267

10.  Influence of beta blockers on survival in dogs with severe subaortic stenosis.

Authors:  B D Eason; D M Fine; D Leeder; C Stauthammer; K Lamb; A H Tobias
Journal:  J Vet Intern Med       Date:  2014-03-05       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.